Last reviewed · How we verify
A Multicenter, Prospective, Cohort Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimibe Under the Real-World Condition
The purpose of this study is to evaluate the efficacy and safety of fixed-Dose combination of Pitavastatin/Ezetimibe under the real-world condition
Details
| Lead sponsor | Boryung Pharmaceutical Co., Ltd |
|---|---|
| Status | RECRUITING |
| Enrolment | 8606 |
| Start date | 2024-03-15 |
| Completion | 2026-06 |
Conditions
- Primary Hypercholesterolemia
- Mixed Dyslipidemia
Primary outcomes
- Rate of reaching the target LDL Cholesterol level — 12 weeks after administration
Countries
South Korea